on 21 Apr 2023
Last Applicant/ Owned by
CH-4002 Basel
CH
Serial Number
79173425 filed on 17th Jun 2015
Registration Number
5051723 registered on 04th Oct 2016
Filing Basis
1. filing basis filed as 66 a
Disclaimer
NO DATA
Medical services, namely, in the field of gene and cellular immunotherapies and transplantation and medical diagnostic testing, monitoring and reporting services; medical treatment services in the field of oncology; blood testing for the purpose of medical clinical diagnosis; consulting services in the fields of medical treatment and medicines, medical diagnostic testing, and diagnostic and clinic Read More
Medical services, namely, in the field of gene and cellular immunotherapies and transplantation and medical diagnostic testing, monitoring and reporting services; medical treatment services in the field of oncology; blood testing for the purpose of medical clinical diagnosis; consulting services in the fields of medical treatment and medicines, medical diagnostic testing, and diagnostic and clinical blood treatment procedures; human biological cell banking services, namely, the collection, preservation, and storage of human biological tissue; collection and preservation of human blood and cells for medical use; providing medical information, namely, hosting a patient support call center regarding gene and cellular immunotherapies and transplantation
No 79173425
No Service Mark
No
No
No
No
No
Yes
Yes
No
No
Status Date | Action Taken |
---|---|
29th Jan 2024 | TOTAL INVALIDATION PROCESSED BY THE IB |
06th Jan 2024 | INVALIDATION PROCESSED |
06th Jan 2024 | TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB |
21st Dec 2023 | TOTAL INVALIDATION OF REG EXT PROTECTION CREATED |
21st Apr 2023 | CANCELLED SECTION 71 |
04th Oct 2021 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED |
17th Feb 2017 | FINAL DECISION TRANSACTION PROCESSED BY IB |
10th Jan 2017 | FINAL DISPOSITION PROCESSED |
10th Jan 2017 | FINAL DISPOSITION NOTICE SENT TO IB |
04th Jan 2017 | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB |